Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2004 Jun;59(6):529–535. doi: 10.1136/thx.2003.006528

α1-Antitrypsin deficiency • 4: Molecular pathophysiology

D Lomas, H Parfrey
PMCID: PMC1747018  PMID: 15170041

Abstract

The molecular basis of α1-antitrypsin deficiency is reviewed and is shown to be due to the accumulation of mutant protein as ordered polymers within the endoplasmic reticulum of hepatocytes. The current goals are to determine the cellular response to polymeric α1-antitrypsin and to develop therapeutic strategies to block polymerisation in vivo.

Full Text

The Full Text of this article is available as a PDF (499.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aronsen K. F., Ekelund G., Kindmark C. O., Laurell C. B. Sequential changes of plasma proteins after surgical trauma. Scand J Clin Lab Invest Suppl. 1972;124:127–136. doi: 10.3109/00365517209102760. [DOI] [PubMed] [Google Scholar]
  2. Aulak K. S., Eldering E., Hack C. E., Lubbers Y. P., Harrison R. A., Mast A., Cicardi M., Davis A. E., 3rd A hinge region mutation in C1-inhibitor (Ala436-->Thr) results in nonsubstrate-like behavior and in polymerization of the molecule. J Biol Chem. 1993 Aug 25;268(24):18088–18094. [PubMed] [Google Scholar]
  3. Banda M. J., Rice A. G., Griffin G. L., Senior R. M. The inhibitory complex of human alpha 1-proteinase inhibitor and human leukocyte elastase is a neutrophil chemoattractant. J Exp Med. 1988 May 1;167(5):1608–1615. doi: 10.1084/jem.167.5.1608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Baslund B., Szpirt W., Eriksson S., Elzouki A. N., Wiik A., Wieslander J., Petersen J. Complexes between proteinase 3, alpha 1-antitrypsin and proteinase 3 anti-neutrophil cytoplasm autoantibodies: a comparison between alpha 1-antitrypsin PiZ allele carriers and non-carriers with Wegener's granulomatosis. Eur J Clin Invest. 1996 Sep;26(9):786–792. doi: 10.1046/j.1365-2362.1996.2070553.x. [DOI] [PubMed] [Google Scholar]
  5. Beatty K., Bieth J., Travis J. Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. J Biol Chem. 1980 May 10;255(9):3931–3934. [PubMed] [Google Scholar]
  6. Belorgey Didier, Crowther Damian C., Mahadeva Ravi, Lomas David A. Mutant Neuroserpin (S49P) that causes familial encephalopathy with neuroserpin inclusion bodies is a poor proteinase inhibitor and readily forms polymers in vitro. J Biol Chem. 2002 Mar 5;277(19):17367–17373. doi: 10.1074/jbc.M200680200. [DOI] [PubMed] [Google Scholar]
  7. Billingsley G. D., Walter M. A., Hammond G. L., Cox D. W. Physical mapping of four serpin genes: alpha 1-antitrypsin, alpha 1-antichymotrypsin, corticosteroid-binding globulin, and protein C inhibitor, within a 280-kb region on chromosome I4q32.1. Am J Hum Genet. 1993 Feb;52(2):343–353. [PMC free article] [PubMed] [Google Scholar]
  8. Blanco I., Fernández E., Bustillo E. F. Alpha-1-antitrypsin PI phenotypes S and Z in Europe: an analysis of the published surveys. Clin Genet. 2001 Jul;60(1):31–41. doi: 10.1034/j.1399-0004.2001.600105.x. [DOI] [PubMed] [Google Scholar]
  9. Brantly M., Nukiwa T., Crystal R. G. Molecular basis of alpha-1-antitrypsin deficiency. Am J Med. 1988 Jun 24;84(6A):13–31. doi: 10.1016/0002-9343(88)90154-4. [DOI] [PubMed] [Google Scholar]
  10. Bruce D., Perry D. J., Borg J. Y., Carrell R. W., Wardell M. R. Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 Asn-->Asp) J Clin Invest. 1994 Dec;94(6):2265–2274. doi: 10.1172/JCI117589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Burrows J. A., Willis L. K., Perlmutter D. H. Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency. Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1796–1801. doi: 10.1073/pnas.97.4.1796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cabral C. M., Choudhury P., Liu Y., Sifers R. N. Processing by endoplasmic reticulum mannosidases partitions a secretion-impaired glycoprotein into distinct disposal pathways. J Biol Chem. 2000 Aug 11;275(32):25015–25022. doi: 10.1074/jbc.M910172199. [DOI] [PubMed] [Google Scholar]
  13. Cabral C. M., Liu Y., Sifers R. N. Dissecting glycoprotein quality control in the secretory pathway. Trends Biochem Sci. 2001 Oct;26(10):619–624. doi: 10.1016/s0968-0004(01)01942-9. [DOI] [PubMed] [Google Scholar]
  14. Cabral Christopher M., Liu Yan, Moremen Kelley W., Sifers Richard N. Organizational diversity among distinct glycoprotein endoplasmic reticulum-associated degradation programs. Mol Biol Cell. 2002 Aug;13(8):2639–2650. doi: 10.1091/mbc.E02-02-0068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Campra J. L., Craig J. R., Peters R. L., Reynolds T. B. Cirrhosis associated with partial deficiency of alpha-1 antitrypsin in an adult. Ann Intern Med. 1973 Feb;78(2):233–238. doi: 10.7326/0003-4819-78-2-233. [DOI] [PubMed] [Google Scholar]
  16. Carlson J. A., Rogers B. B., Sifers R. N., Finegold M. J., Clift S. M., DeMayo F. J., Bullock D. W., Woo S. L. Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice. J Clin Invest. 1989 Apr;83(4):1183–1190. doi: 10.1172/JCI113999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Carrell R. W., Jeppsson J. O., Laurell C. B., Brennan S. O., Owen M. C., Vaughan L., Boswell D. R. Structure and variation of human alpha 1-antitrypsin. Nature. 1982 Jul 22;298(5872):329–334. doi: 10.1038/298329a0. [DOI] [PubMed] [Google Scholar]
  18. Carrell Robin W., Lomas David A. Alpha1-antitrypsin deficiency--a model for conformational diseases. N Engl J Med. 2002 Jan 3;346(1):45–53. doi: 10.1056/NEJMra010772. [DOI] [PubMed] [Google Scholar]
  19. Chang W. S., Wardell M. R., Lomas D. A., Carrell R. W. Probing serpin reactive-loop conformations by proteolytic cleavage. Biochem J. 1996 Mar 1;314(Pt 2):647–653. doi: 10.1042/bj3140647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Chow M. K., Devlin G. L., Bottomley S. P. Osmolytes as modulators of conformational changes in serpins. Biol Chem. 2001 Nov;382(11):1593–1599. doi: 10.1515/BC.2001.194. [DOI] [PubMed] [Google Scholar]
  21. Cichy J., Potempa J., Travis J. Biosynthesis of alpha1-proteinase inhibitor by human lung-derived epithelial cells. J Biol Chem. 1997 Mar 28;272(13):8250–8255. doi: 10.1074/jbc.272.13.8250. [DOI] [PubMed] [Google Scholar]
  22. Colp C., Pappas J., Moran D., Lieberman J. Variants of alpha 1-antitrypsin in Puerto Rican children with asthma. Chest. 1993 Mar;103(3):812–815. doi: 10.1378/chest.103.3.812. [DOI] [PubMed] [Google Scholar]
  23. Cox D. W. Alpha 1-antitrypsin: a guardian of vascular tissue. Mayo Clin Proc. 1994 Nov;69(11):1123–1124. doi: 10.1016/s0025-6196(12)61385-8. [DOI] [PubMed] [Google Scholar]
  24. Crowther Damian C., Serpell Louise C., Dafforn Timothy R., Gooptu Bibek, Lomas David A. Nucleation of alpha 1-antichymotrypsin polymerization. Biochemistry. 2003 Mar 4;42(8):2355–2363. doi: 10.1021/bi0259305. [DOI] [PubMed] [Google Scholar]
  25. Cruz M., Molina J. A., Pedrola D., Muñoz-López F. Cirrhosis and heterozygous alpha1-antitrypsin deficiency in a 4-year-old girl. Helv Paediatr Acta. 1976 Apr;30(6):501–507. [PubMed] [Google Scholar]
  26. Cuvelier A., Muir J. F., Hellot M. F., Benhamou D., Martin J. P., Bénichou J., Sesboü R. Distribution of alpha(1)-antitrypsin alleles in patients with bronchiectasis. Chest. 2000 Feb;117(2):415–419. doi: 10.1378/chest.117.2.415. [DOI] [PubMed] [Google Scholar]
  27. Dafforn T. R., Mahadeva R., Elliott P. R., Sivasothy P., Lomas D. A. A kinetic mechanism for the polymerization of alpha1-antitrypsin. J Biol Chem. 1999 Apr 2;274(14):9548–9555. doi: 10.1074/jbc.274.14.9548. [DOI] [PubMed] [Google Scholar]
  28. Davis R. L., Shrimpton A. E., Holohan P. D., Bradshaw C., Feiglin D., Collins G. H., Sonderegger P., Kinter J., Becker L. M., Lacbawan F. Familial dementia caused by polymerization of mutant neuroserpin. Nature. 1999 Sep 23;401(6751):376–379. doi: 10.1038/43894. [DOI] [PubMed] [Google Scholar]
  29. Davis Richard L., Shrimpton Antony E., Carrell Robin W., Lomas David A., Gerhard Lieselotte, Baumann Bruno, Lawrence Daniel A., Yepes Manuel, Kim Tai Seung, Ghetti Bernardino. Association between conformational mutations in neuroserpin and onset and severity of dementia. Lancet. 2002 Jun 29;359(9325):2242–2247. doi: 10.1016/S0140-6736(02)09293-0. [DOI] [PubMed] [Google Scholar]
  30. Devlin G. L., Parfrey H., Tew D. J., Lomas D. A., Bottomley S. P. Prevention of polymerization of M and Z alpha1-Antitrypsin (alpha1-AT) with trimethylamine N-oxide. Implications for the treatment of alpha1-at deficiency. Am J Respir Cell Mol Biol. 2001 Jun;24(6):727–732. doi: 10.1165/ajrcmb.24.6.4407. [DOI] [PubMed] [Google Scholar]
  31. Dunstone M. A., Dai W., Whisstock J. C., Rossjohn J., Pike R. N., Feil S. C., Le Bonniec B. F., Parker M. W., Bottomley S. P. Cleaved antitrypsin polymers at atomic resolution. Protein Sci. 2000 Feb;9(2):417–420. doi: 10.1110/ps.9.2.417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Dycaico M. J., Grant S. G., Felts K., Nichols W. S., Geller S. A., Hager J. H., Pollard A. J., Kohler S. W., Short H. P., Jirik F. R. Neonatal hepatitis induced by alpha 1-antitrypsin: a transgenic mouse model. Science. 1988 Dec 9;242(4884):1409–1412. doi: 10.1126/science.3264419. [DOI] [PubMed] [Google Scholar]
  33. Eden E., Mitchell D., Mehlman B., Khouli H., Nejat M., Grieco M. H., Turino G. M. Atopy, asthma, and emphysema in patients with severe alpha-1-antitrypysin deficiency. Am J Respir Crit Care Med. 1997 Jul;156(1):68–74. doi: 10.1164/ajrccm.156.1.9508014. [DOI] [PubMed] [Google Scholar]
  34. Eldering E., Verpy E., Roem D., Meo T., Tosi M. COOH-terminal substitutions in the serpin C1 inhibitor that cause loop overinsertion and subsequent multimerization. J Biol Chem. 1995 Feb 10;270(6):2579–2587. doi: 10.1074/jbc.270.6.2579. [DOI] [PubMed] [Google Scholar]
  35. Elliott P. R., Abrahams J. P., Lomas D. A. Wild-type alpha 1-antitrypsin is in the canonical inhibitory conformation. J Mol Biol. 1998 Jan 23;275(3):419–425. doi: 10.1006/jmbi.1997.1458. [DOI] [PubMed] [Google Scholar]
  36. Elliott P. R., Bilton D., Lomas D. A. Lung polymers in Z alpha1-antitrypsin deficiency-related emphysema. Am J Respir Cell Mol Biol. 1998 May;18(5):670–674. doi: 10.1165/ajrcmb.18.5.3065. [DOI] [PubMed] [Google Scholar]
  37. Elliott P. R., Lomas D. A., Carrell R. W., Abrahams J. P. Inhibitory conformation of the reactive loop of alpha 1-antitrypsin. Nat Struct Biol. 1996 Aug;3(8):676–681. doi: 10.1038/nsb0896-676. [DOI] [PubMed] [Google Scholar]
  38. Elliott P. R., Pei X. Y., Dafforn T. R., Lomas D. A. Topography of a 2.0 A structure of alpha1-antitrypsin reveals targets for rational drug design to prevent conformational disease. Protein Sci. 2000 Jul;9(7):1274–1281. doi: 10.1110/ps.9.7.1274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Elliott P. R., Stein P. E., Bilton D., Carrell R. W., Lomas D. A. Structural explanation for the deficiency of S alpha 1-antitrypsin. Nat Struct Biol. 1996 Nov;3(11):910–911. doi: 10.1038/nsb1196-910. [DOI] [PubMed] [Google Scholar]
  40. Eriksson S., Alm R., Astedt B. Organ cultures of human fetal hepatocytes in the study of extra-and intracellular alpha1-antitrypsin. Biochim Biophys Acta. 1978 Sep 6;542(3):496–505. doi: 10.1016/0304-4165(78)90379-3. [DOI] [PubMed] [Google Scholar]
  41. Eriksson S., Carlson J., Velez R. Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. N Engl J Med. 1986 Mar 20;314(12):736–739. doi: 10.1056/NEJM198603203141202. [DOI] [PubMed] [Google Scholar]
  42. Eriksson S. Studies in alpha 1-antitrypsin deficiency. Acta Med Scand Suppl. 1965;432:1–85. [PubMed] [Google Scholar]
  43. Faber J. P., Poller W., Olek K., Baumann U., Carlson J., Lindmark B., Eriksson S. The molecular basis of alpha 1-antichymotrypsin deficiency in a heterozygote with liver and lung disease. J Hepatol. 1993 Jul;18(3):313–321. doi: 10.1016/s0168-8278(05)80275-2. [DOI] [PubMed] [Google Scholar]
  44. Fitton H. L., Pike R. N., Carrell R. W., Chang W. S. Mechanisms of antithrombin polymerisation and heparin activation probed by the insertion of synthetic reactive loop peptides. Biol Chem. 1997 Sep;378(9):1059–1063. doi: 10.1515/bchm.1997.378.9.1059. [DOI] [PubMed] [Google Scholar]
  45. GROSS P., PFITZER E. A., TOLKER E., BABYAK M. A., KASCHAK M. EXPERIMENTAL EMPHYSEMA: ITS PRODUCTION WITH PAPAIN IN NORMAL AND SILICOTIC RATS. Arch Environ Health. 1965 Jul;11:50–58. doi: 10.1080/00039896.1965.10664169. [DOI] [PubMed] [Google Scholar]
  46. Gadek J. E., Fells G. A., Crystal R. G. Cigarette smoking induces functional antiprotease deficiency in the lower respiratory tract of humans. Science. 1979 Dec 14;206(4424):1315–1316. doi: 10.1126/science.316188. [DOI] [PubMed] [Google Scholar]
  47. Gooptu B., Hazes B., Chang W. S., Dafforn T. R., Carrell R. W., Read R. J., Lomas D. A. Inactive conformation of the serpin alpha(1)-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease. Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):67–72. doi: 10.1073/pnas.97.1.67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Green Clare, Brown Gemma, Dafforn Timothy R., Reichhart Jean-Marc, Morley Terri, Lomas David A., Gubb David. Drosophila necrotic mutations mirror disease-associated variants of human serpins. Development. 2003 Apr;130(7):1473–1478. doi: 10.1242/dev.00350. [DOI] [PubMed] [Google Scholar]
  49. Griffith M. E., Lovegrove J. U., Gaskin G., Whitehouse D. B., Pusey C. D. C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1-antitrypsin, and P-antineutrophil cytoplasmic antibody positivity with the S allele. Nephrol Dial Transplant. 1996 Mar;11(3):438–443. [PubMed] [Google Scholar]
  50. Guzdek A., Potempa J., Dubin A., Travis J. Comparative properties of human alpha-1-proteinase inhibitor glycosylation variants. FEBS Lett. 1990 Oct 15;272(1-2):125–127. doi: 10.1016/0014-5793(90)80464-t. [DOI] [PubMed] [Google Scholar]
  51. Hubbard R. C., Fells G., Gadek J., Pacholok S., Humes J., Crystal R. G. Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages. J Clin Invest. 1991 Sep;88(3):891–897. doi: 10.1172/JCI115391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Huber R., Carrell R. W. Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins. Biochemistry. 1989 Nov 14;28(23):8951–8966. doi: 10.1021/bi00449a001. [DOI] [PubMed] [Google Scholar]
  53. Huntington J. A., Pannu N. S., Hazes B., Read R. J., Lomas D. A., Carrell R. W. A 2.6 A structure of a serpin polymer and implications for conformational disease. J Mol Biol. 1999 Oct 29;293(3):449–455. doi: 10.1006/jmbi.1999.3184. [DOI] [PubMed] [Google Scholar]
  54. Huntington J. A., Read R. J., Carrell R. W. Structure of a serpin-protease complex shows inhibition by deformation. Nature. 2000 Oct 19;407(6806):923–926. doi: 10.1038/35038119. [DOI] [PubMed] [Google Scholar]
  55. Im Hana, Woo Mi-Sook, Hwang Kwang Yeon, Yu Myeong-Hee. Interactions causing the kinetic trap in serpin protein folding. J Biol Chem. 2002 Sep 18;277(48):46347–46354. doi: 10.1074/jbc.M207682200. [DOI] [PubMed] [Google Scholar]
  56. Janciauskiene Sabina, Dominaitiene Ruta, Sternby Nils H., Piitulainen Eva, Eriksson Sten. Detection of circulating and endothelial cell polymers of Z and wild type alpha 1-antitrypsin by a monoclonal antibody. J Biol Chem. 2002 May 22;277(29):26540–26546. doi: 10.1074/jbc.M203832200. [DOI] [PubMed] [Google Scholar]
  57. Janoff A., Carp H., Lee D. K., Drew R. T. Cigarette smoke inhalation decreases alpha 1-antitrypsin activity in rat lung. Science. 1979 Dec 14;206(4424):1313–1314. doi: 10.1126/science.316187. [DOI] [PubMed] [Google Scholar]
  58. Janoff A., Sloan B., Weinbaum G., Damiano V., Sandhaus R. A., Elias J., Kimbel P. Experimental emphysema induced with purified human neutrophil elastase: tissue localization of the instilled protease. Am Rev Respir Dis. 1977 Mar;115(3):461–478. doi: 10.1164/arrd.1977.115.3.461. [DOI] [PubMed] [Google Scholar]
  59. Janus E. D., Phillips N. T., Carrell R. W. Smoking, lung function, and alpha 1-antitrypsin deficiency. Lancet. 1985 Jan 19;1(8421):152–154. doi: 10.1016/s0140-6736(85)91916-6. [DOI] [PubMed] [Google Scholar]
  60. Jeppsson J. O. Amino acid substitution Glu leads to Lys alpha1-antitrypsin PiZ. FEBS Lett. 1976 Jun 1;65(2):195–197. doi: 10.1016/0014-5793(76)80478-4. [DOI] [PubMed] [Google Scholar]
  61. Johnson D., Travis J. Structural evidence for methionine at the reactive site of human alpha-1-proteinase inhibitor. J Biol Chem. 1978 Oct 25;253(20):7142–7144. [PubMed] [Google Scholar]
  62. Kang H. A., Lee K. N., Yu M. H. Folding and stability of the Z and S(iiyama) genetic variants of human alpha1-antitrypsin. J Biol Chem. 1997 Jan 3;272(1):510–516. [PubMed] [Google Scholar]
  63. Kim J., Lee K. N., Yi G. S., Yu M. H. A thermostable mutation located at the hydrophobic core of alpha 1-antitrypsin suppresses the folding defect of the Z-type variant. J Biol Chem. 1995 Apr 14;270(15):8597–8601. doi: 10.1074/jbc.270.15.8597. [DOI] [PubMed] [Google Scholar]
  64. Kim S., Woo J., Seo E. J., Yu M., Ryu S. A 2.1 A resolution structure of an uncleaved alpha(1)-antitrypsin shows variability of the reactive center and other loops. J Mol Biol. 2001 Feb 9;306(1):109–119. doi: 10.1006/jmbi.2000.4357. [DOI] [PubMed] [Google Scholar]
  65. King M. A., Stone J. A., Diaz P. T., Mueller C. F., Becker W. J., Gadek J. E. Alpha 1-antitrypsin deficiency: evaluation of bronchiectasis with CT. Radiology. 1996 Apr;199(1):137–141. doi: 10.1148/radiology.199.1.8633137. [DOI] [PubMed] [Google Scholar]
  66. Koj A., Regoeczi E., Toews C. J., Leveille R., Gauldie J. Synthesis of antithrombin III and alpha-1-antitrypsin by the perfused rat liver. Biochim Biophys Acta. 1978 Apr 3;539(4):496–504. doi: 10.1016/0304-4165(78)90083-1. [DOI] [PubMed] [Google Scholar]
  67. Kubba A. K., Young M. The long suffering of Frederic Chopin. Chest. 1998 Jan;113(1):210–216. doi: 10.1378/chest.113.1.210. [DOI] [PubMed] [Google Scholar]
  68. Kuzemko J. A. Chopin's illnesses. J R Soc Med. 1994 Dec;87(12):769–772. [PMC free article] [PubMed] [Google Scholar]
  69. Larsson C. Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z. Acta Med Scand. 1978;204(5):345–351. doi: 10.1111/j.0954-6820.1978.tb08452.x. [DOI] [PubMed] [Google Scholar]
  70. Le A., Ferrell G. A., Dishon D. S., Le Q. Q., Sifers R. N. Soluble aggregates of the human PiZ alpha 1-antitrypsin variant are degraded within the endoplasmic reticulum by a mechanism sensitive to inhibitors of protein synthesis. J Biol Chem. 1992 Jan 15;267(2):1072–1080. [PubMed] [Google Scholar]
  71. Lee C., Maeng J. S., Kocher J. P., Lee B., Yu M. H. Cavities of alpha(1)-antitrypsin that play structural and functional roles. Protein Sci. 2001 Jul;10(7):1446–1453. doi: 10.1110/ps.840101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Lindo V. S., Kakkar V. V., Learmonth M., Melissari E., Zappacosta F., Panico M., Morris H. R. Antithrombin-TRI (Ala382 to Thr) causing severe thromboembolic tendency undergoes the S-to-R transition and is associated with a plasma-inactive high-molecular-weight complex of aggregated antithrombin. Br J Haematol. 1995 Mar;89(3):589–601. doi: 10.1111/j.1365-2141.1995.tb08368.x. [DOI] [PubMed] [Google Scholar]
  73. Llewellyn-Jones C. G., Lomas D. A., Carrell R. W., Stockley R. A. The effect of the Z mutation on the ability of alpha 1-antitrypsin to prevent neutrophil mediated tissue damage. Biochim Biophys Acta. 1994 Nov 29;1227(3):155–160. doi: 10.1016/0925-4439(94)90089-2. [DOI] [PubMed] [Google Scholar]
  74. Lomas D. A., Elliott P. R., Chang W. S., Wardell M. R., Carrell R. W. Preparation and characterization of latent alpha 1-antitrypsin. J Biol Chem. 1995 Mar 10;270(10):5282–5288. doi: 10.1074/jbc.270.10.5282. [DOI] [PubMed] [Google Scholar]
  75. Lomas D. A., Elliott P. R., Sidhar S. K., Foreman R. C., Finch J. T., Cox D. W., Whisstock J. C., Carrell R. W. alpha 1-Antitrypsin Mmalton (Phe52-deleted) forms loop-sheet polymers in vivo. Evidence for the C sheet mechanism of polymerization. J Biol Chem. 1995 Jul 14;270(28):16864–16870. doi: 10.1074/jbc.270.28.16864. [DOI] [PubMed] [Google Scholar]
  76. Lomas D. A., Evans D. L., Finch J. T., Carrell R. W. The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature. 1992 Jun 18;357(6379):605–607. doi: 10.1038/357605a0. [DOI] [PubMed] [Google Scholar]
  77. Lomas D. A., Evans D. L., Stone S. R., Chang W. S., Carrell R. W. Effect of the Z mutation on the physical and inhibitory properties of alpha 1-antitrypsin. Biochemistry. 1993 Jan 19;32(2):500–508. doi: 10.1021/bi00053a014. [DOI] [PubMed] [Google Scholar]
  78. Lomas D. A., Finch J. T., Seyama K., Nukiwa T., Carrell R. W. Alpha 1-antitrypsin Siiyama (Ser53-->Phe). Further evidence for intracellular loop-sheet polymerization. J Biol Chem. 1993 Jul 25;268(21):15333–15335. [PubMed] [Google Scholar]
  79. Lomas David A., Carrell Robin W. Serpinopathies and the conformational dementias. Nat Rev Genet. 2002 Oct;3(10):759–768. doi: 10.1038/nrg907. [DOI] [PubMed] [Google Scholar]
  80. Lomas David A., Mahadeva Ravi. Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. J Clin Invest. 2002 Dec;110(11):1585–1590. doi: 10.1172/JCI16782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Mahadeva R., Chang W. S., Dafforn T. R., Oakley D. J., Foreman R. C., Calvin J., Wight D. G., Lomas D. A. Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis. J Clin Invest. 1999 Apr;103(7):999–1006. doi: 10.1172/JCI4874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Mahadeva R., Lomas D. A. Genetics and respiratory disease. 2. Alpha 1-antitrypsin deficiency, cirrhosis and emphysema. Thorax. 1998 Jun;53(6):501–505. doi: 10.1136/thx.53.6.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Mahadeva Ravi, Dafforn Timothy R., Carrell Robin W., Lomas David A. 6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. Implications for the prevention of Z alpha(1)-antitrypsin-related cirrhosis. J Biol Chem. 2001 Dec 28;277(9):6771–6774. doi: 10.1074/jbc.C100722200. [DOI] [PubMed] [Google Scholar]
  84. Mast A. E., Enghild J. J., Pizzo S. V., Salvesen G. Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, antithrombin III, alpha 2-antiplasmin, angiotensinogen, and ovalbumin. Biochemistry. 1991 Feb 12;30(6):1723–1730. doi: 10.1021/bi00220a039. [DOI] [PubMed] [Google Scholar]
  85. Mast A. E., Enghild J. J., Salvesen G. Conformation of the reactive site loop of alpha 1-proteinase inhibitor probed by limited proteolysis. Biochemistry. 1992 Mar 17;31(10):2720–2728. doi: 10.1021/bi00125a012. [DOI] [PubMed] [Google Scholar]
  86. Matsunaga E., Shiokawa S., Nakamura H., Maruyama T., Tsuda K., Fukumaki Y. Molecular analysis of the gene of the alpha 1-antitrypsin deficiency variant, Mnichinan. Am J Hum Genet. 1990 Mar;46(3):602–612. [PMC free article] [PubMed] [Google Scholar]
  87. Mornex J. F., Chytil-Weir A., Martinet Y., Courtney M., LeCocq J. P., Crystal R. G. Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin-deficient individuals. J Clin Invest. 1986 Jun;77(6):1952–1961. doi: 10.1172/JCI112524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Morrison H. M., Kramps J. A., Burnett D., Stockley R. A. Lung lavage fluid from patients with alpha 1-proteinase inhibitor deficiency or chronic obstructive bronchitis: anti-elastase function and cell profile. Clin Sci (Lond) 1987 Mar;72(3):373–381. doi: 10.1042/cs0720373. [DOI] [PubMed] [Google Scholar]
  89. Novoradovskaya N., Lee J., Yu Z. X., Ferrans V. J., Brantly M. Inhibition of intracellular degradation increases secretion of a mutant form of alpha1-antitrypsin associated with profound deficiency. J Clin Invest. 1998 Jun 15;101(12):2693–2701. doi: 10.1172/JCI549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. O'Riordan K., Blei A., Rao M. S., Abecassis M. alpha 1-antitrypsin deficiency-associated panniculitis: resolution with intravenous alpha 1-antitrypsin administration and liver transplantation. Transplantation. 1997 Feb 15;63(3):480–482. doi: 10.1097/00007890-199702150-00028. [DOI] [PubMed] [Google Scholar]
  91. Ogushi F., Fells G. A., Hubbard R. C., Straus S. D., Crystal R. G. Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase. J Clin Invest. 1987 Nov;80(5):1366–1374. doi: 10.1172/JCI113214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Owen M. C., Carrell R. W., Brennan S. O. The abnormality of the S variant of human alpha-1-antitrypsin. Biochim Biophys Acta. 1976 Nov 26;453(1):257–261. doi: 10.1016/0005-2795(76)90271-3. [DOI] [PubMed] [Google Scholar]
  93. Parfrey Helen, Mahadeva Ravi, Ravenhill Neil A., Zhou Aiwu, Dafforn Timothy R., Foreman Richard C., Lomas David A. Targeting a surface cavity of alpha 1-antitrypsin to prevent conformational disease. J Biol Chem. 2003 Jun 13;278(35):33060–33066. doi: 10.1074/jbc.M302646200. [DOI] [PubMed] [Google Scholar]
  94. Parmar Jasvir S., Mahadeva Ravi, Reed Benjamin J., Farahi Neda, Cadwallader Karen A., Keogan Mary T., Bilton Diana, Chilvers Edwin R., Lomas David A. Polymers of alpha(1)-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysema. Am J Respir Cell Mol Biol. 2002 Jun;26(6):723–730. doi: 10.1165/ajrcmb.26.6.4739. [DOI] [PubMed] [Google Scholar]
  95. Perlmutter D. H., Daniels J. D., Auerbach H. S., De Schryver-Kecskemeti K., Winter H. S., Alpers D. H. The alpha 1-antitrypsin gene is expressed in a human intestinal epithelial cell line. J Biol Chem. 1989 Jun 5;264(16):9485–9490. [PubMed] [Google Scholar]
  96. Perlmutter David H. Liver injury in alpha1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury. J Clin Invest. 2002 Dec;110(11):1579–1583. doi: 10.1172/JCI16787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Piitulainen E., Eriksson S. Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ). Eur Respir J. 1999 Feb;13(2):247–251. doi: 10.1183/09031936.99.13224799. [DOI] [PubMed] [Google Scholar]
  98. Poller W., Faber J. P., Weidinger S., Tief K., Scholz S., Fischer M., Olek K., Kirchgesser M., Heidtmann H. H. A leucine-to-proline substitution causes a defective alpha 1-antichymotrypsin allele associated with familial obstructive lung disease. Genomics. 1993 Sep;17(3):740–743. doi: 10.1006/geno.1993.1396. [DOI] [PubMed] [Google Scholar]
  99. Potempa J., Korzus E., Travis J. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J Biol Chem. 1994 Jun 10;269(23):15957–15960. [PubMed] [Google Scholar]
  100. Qu D., Teckman J. H., Omura S., Perlmutter D. H. Degradation of a mutant secretory protein, alpha1-antitrypsin Z, in the endoplasmic reticulum requires proteasome activity. J Biol Chem. 1996 Sep 13;271(37):22791–22795. doi: 10.1074/jbc.271.37.22791. [DOI] [PubMed] [Google Scholar]
  101. Rao N. V., Wehner N. G., Marshall B. C., Gray W. R., Gray B. H., Hoidal J. R. Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties. J Biol Chem. 1991 May 25;266(15):9540–9548. [PubMed] [Google Scholar]
  102. Rubenstein R. C., Egan M. E., Zeitlin P. L. In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR. J Clin Invest. 1997 Nov 15;100(10):2457–2465. doi: 10.1172/JCI119788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Rubenstein R. C., Zeitlin P. L. A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: partial restoration of nasal epithelial CFTR function. Am J Respir Crit Care Med. 1998 Feb;157(2):484–490. doi: 10.1164/ajrccm.157.2.9706088. [DOI] [PubMed] [Google Scholar]
  104. Ryu S. E., Choi H. J., Kwon K. S., Lee K. N., Yu M. H. The native strains in the hydrophobic core and flexible reactive loop of a serine protease inhibitor: crystal structure of an uncleaved alpha1-antitrypsin at 2.7 A. Structure. 1996 Oct 15;4(10):1181–1192. doi: 10.1016/s0969-2126(96)00126-8. [DOI] [PubMed] [Google Scholar]
  105. SCHULTZE H. E., HEIDE K., HAUPT H. [alpha1-Antitrypsin from human serum]. Klin Wochenschr. 1962 Apr 15;40:427–429. doi: 10.1007/BF01732842. [DOI] [PubMed] [Google Scholar]
  106. Schievink W. I., Prakash U. B., Piepgras D. G., Mokri B. Alpha 1-antitrypsin deficiency in intracranial aneurysms and cervical artery dissection. Lancet. 1994 Feb 19;343(8895):452–453. doi: 10.1016/s0140-6736(94)92693-x. [DOI] [PubMed] [Google Scholar]
  107. Schulze A. J., Baumann U., Knof S., Jaeger E., Huber R., Laurell C. B. Structural transition of alpha 1-antitrypsin by a peptide sequentially similar to beta-strand s4A. Eur J Biochem. 1990 Nov 26;194(1):51–56. doi: 10.1111/j.1432-1033.1990.tb19425.x. [DOI] [PubMed] [Google Scholar]
  108. Seersholm N., Kok-Jensen A., Dirksen A. Survival of patients with severe alpha 1-antitrypsin deficiency with special reference to non-index cases. Thorax. 1994 Jul;49(7):695–698. doi: 10.1136/thx.49.7.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Senior R. M., Griffin G. L., Mecham R. P. Chemotactic activity of elastin-derived peptides. J Clin Invest. 1980 Oct;66(4):859–862. doi: 10.1172/JCI109926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Senior R. M., Tegner H., Kuhn C., Ohlsson K., Starcher B. C., Pierce J. A. The induction of pulmonary emphysema with human leukocyte elastase. Am Rev Respir Dis. 1977 Sep;116(3):469–475. doi: 10.1164/arrd.1977.116.3.469. [DOI] [PubMed] [Google Scholar]
  111. Sergi C., Consalez G. G., Fabbretti G., Brisigotti M., Faa G., Costa V., Romeo G., Callea F. Immunohistochemical and genetic characterization of the M Cagliari alpha-1-antitrypsin molecule (M-like alpha-1-antitrypsin deficiency). Lab Invest. 1994 Jan;70(1):130–133. [PubMed] [Google Scholar]
  112. Seyama K., Nukiwa T., Souma S., Shimizu K., Kira S. Alpha 1-antitrypsin-deficient variant Siiyama (Ser53[TCC] to Phe53[TTC]) is prevalent in Japan. Status of alpha 1-antitrypsin deficiency in Japan. Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):2119–2126. doi: 10.1164/ajrccm.152.6.8520784. [DOI] [PubMed] [Google Scholar]
  113. Seyama K., Nukiwa T., Takabe K., Takahashi H., Miyake K., Kira S. Siiyama (serine 53 (TCC) to phenylalanine 53 (TTC)). A new alpha 1-antitrypsin-deficient variant with mutation on a predicted conserved residue of the serpin backbone. J Biol Chem. 1991 Jul 5;266(19):12627–12632. [PubMed] [Google Scholar]
  114. Sharp H. L., Bridges R. A., Krivit W., Freier E. F. Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder. J Lab Clin Med. 1969 Jun;73(6):934–939. [PubMed] [Google Scholar]
  115. Sidhar S. K., Lomas D. A., Carrell R. W., Foreman R. C. Mutations which impede loop/sheet polymerization enhance the secretion of human alpha 1-antitrypsin deficiency variants. J Biol Chem. 1995 Apr 14;270(15):8393–8396. doi: 10.1074/jbc.270.15.8393. [DOI] [PubMed] [Google Scholar]
  116. Silverman G. A., Bird P. I., Carrell R. W., Church F. C., Coughlin P. B., Gettins P. G., Irving J. A., Lomas D. A., Luke C. J., Moyer R. W. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem. 2001 Jul 2;276(36):33293–33296. doi: 10.1074/jbc.R100016200. [DOI] [PubMed] [Google Scholar]
  117. Sivasothy P., Dafforn T. R., Gettins P. G., Lomas D. A. Pathogenic alpha 1-antitrypsin polymers are formed by reactive loop-beta-sheet A linkage. J Biol Chem. 2000 Oct 27;275(43):33663–33668. doi: 10.1074/jbc.M004054200. [DOI] [PubMed] [Google Scholar]
  118. Skinner R., Chang W. S., Jin L., Pei X., Huntington J. A., Abrahams J. P., Carrell R. W., Lomas D. A. Implications for function and therapy of a 2.9 A structure of binary-complexed antithrombin. J Mol Biol. 1998;283(1):9–14. doi: 10.1006/jmbi.1998.2083. [DOI] [PubMed] [Google Scholar]
  119. Snider G. L., Lucey E. C., Christensen T. G., Stone P. J., Calore J. D., Catanese A., Franzblau C. Emphysema and bronchial secretory cell metaplasia induced in hamsters by human neutrophil products. Am Rev Respir Dis. 1984 Jan;129(1):155–160. doi: 10.1164/arrd.1984.129.1.155. [DOI] [PubMed] [Google Scholar]
  120. Stratikos E., Gettins P. G. Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70 A and full insertion of the reactive center loop into beta-sheet A. Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):4808–4813. doi: 10.1073/pnas.96.9.4808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Stratikos E., Gettins P. G. Major proteinase movement upon stable serpin-proteinase complex formation. Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):453–458. doi: 10.1073/pnas.94.2.453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Stratikos E., Gettins P. G. Mapping the serpin-proteinase complex using single cysteine variants of alpha1-proteinase inhibitor Pittsburgh. J Biol Chem. 1998 Jun 19;273(25):15582–15589. doi: 10.1074/jbc.273.25.15582. [DOI] [PubMed] [Google Scholar]
  123. Sveger T. Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med. 1976 Jun 10;294(24):1316–1321. doi: 10.1056/NEJM197606102942404. [DOI] [PubMed] [Google Scholar]
  124. Sveger T. The natural history of liver disease in alpha 1-antitrypsin deficient children. Acta Paediatr Scand. 1988 Nov;77(6):847–851. doi: 10.1111/j.1651-2227.1988.tb10767.x. [DOI] [PubMed] [Google Scholar]
  125. Teckman J. H., Burrows J., Hidvegi T., Schmidt B., Hale P. D., Perlmutter D. H. The proteasome participates in degradation of mutant alpha 1-antitrypsin Z in the endoplasmic reticulum of hepatoma-derived hepatocytes. J Biol Chem. 2001 Sep 27;276(48):44865–44872. doi: 10.1074/jbc.M103703200. [DOI] [PubMed] [Google Scholar]
  126. Teckman J. H., Perlmutter D. H. Retention of mutant alpha(1)-antitrypsin Z in endoplasmic reticulum is associated with an autophagic response. Am J Physiol Gastrointest Liver Physiol. 2000 Nov;279(5):G961–G974. doi: 10.1152/ajpgi.2000.279.5.G961. [DOI] [PubMed] [Google Scholar]
  127. Teckman J. H., Perlmutter D. H. The endoplasmic reticulum degradation pathway for mutant secretory proteins alpha1-antitrypsin Z and S is distinct from that for an unassembled membrane protein. J Biol Chem. 1996 May 31;271(22):13215–13220. doi: 10.1074/jbc.271.22.13215. [DOI] [PubMed] [Google Scholar]
  128. Warter J., Storck D., Grosshans E., Metais P., Kuntz J. L., Klumpp T. Syndrome de Weber-Christian associé à un déficit en alpha-I-antitrypsine. Enquéte familiale. Ann Med Interne (Paris) 1972 Oct;123(10):877–882. [PubMed] [Google Scholar]
  129. Wewers M. D., Casolaro M. A., Sellers S. E., Swayze S. C., McPhaul K. M., Wittes J. T., Crystal R. G. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema. N Engl J Med. 1987 Apr 23;316(17):1055–1062. doi: 10.1056/NEJM198704233161704. [DOI] [PubMed] [Google Scholar]
  130. Whisstock J., Skinner R., Lesk A. M. An atlas of serpin conformations. Trends Biochem Sci. 1998 Feb;23(2):63–67. doi: 10.1016/s0968-0004(97)01172-9. [DOI] [PubMed] [Google Scholar]
  131. Wilczynska M., Fa M., Karolin J., Ohlsson P. I., Johansson L. B., Ny T. Structural insights into serpin-protease complexes reveal the inhibitory mechanism of serpins. Nat Struct Biol. 1997 May;4(5):354–357. doi: 10.1038/nsb0597-354. [DOI] [PubMed] [Google Scholar]
  132. Wilczynska M., Fa M., Ohlsson P. I., Ny T. The inhibition mechanism of serpins. Evidence that the mobile reactive center loop is cleaved in the native protease-inhibitor complex. J Biol Chem. 1995 Dec 15;270(50):29652–29655. doi: 10.1074/jbc.270.50.29652. [DOI] [PubMed] [Google Scholar]
  133. Woolhouse I. S., Bayley D. L., Stockley R. A. Sputum chemotactic activity in chronic obstructive pulmonary disease: effect of alpha(1)-antitrypsin deficiency and the role of leukotriene B(4) and interleukin 8. Thorax. 2002 Aug;57(8):709–714. doi: 10.1136/thorax.57.8.709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Wu Y., Whitman I., Molmenti E., Moore K., Hippenmeyer P., Perlmutter D. H. A lag in intracellular degradation of mutant alpha 1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha 1-antitrypsin deficiency. Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):9014–9018. doi: 10.1073/pnas.91.19.9014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Yoshida A., Lieberman J., Gaidulis L., Ewing C. Molecular abnormality of human alpha1-antitrypsin variant (Pi-ZZ) associated with plasma activity deficiency. Proc Natl Acad Sci U S A. 1976 Apr;73(4):1324–1328. doi: 10.1073/pnas.73.4.1324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Yu M. H., Lee K. N., Kim J. The Z type variation of human alpha 1-antitrypsin causes a protein folding defect. Nat Struct Biol. 1995 May;2(5):363–367. doi: 10.1038/nsb0595-363. [DOI] [PubMed] [Google Scholar]
  137. Zhou Aiwu, Stein Penelope E., Huntington James A., Carrell Robin W. Serpin polymerization is prevented by a hydrogen bond network that is centered on his-334 and stabilized by glycerol. J Biol Chem. 2003 Feb 10;278(17):15116–15122. doi: 10.1074/jbc.M211663200. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES